Laura E. Benjamin
- Cancer Research top 0.5%
- Cancer, Hypoxia, and Metabolism 16
- Immunology and Allergy top 0.5%
- Cell Adhesion Molecules Research 4
- Molecular Biology top 0.5%
- Angiogenesis and VEGF in Cancer 34
- PI3K/AKT/mTOR signaling in cancer 9
- Oncology top 1%
- Lymphatic System and Diseases 6
- Vascular Tumors and Angiosarcomas 4
- Cell Biology top 1%
- Hippo pathway signaling and YAP/TAZ 5
-
- Sarcoma Diagnosis and Treatment 4
- Co-authors
- Gabriele BergersEli KeshetItzhak HemoAhuva ItinDov PodeDragan GolijaninJanice A. NagyHarold F. Dvorak
- Journals
- Cancer Research (12 papers)Proceedings of the National Academy of Sciences (5 papers)American Journal Of Pathology (3 papers)
- Partner nations
- United StatesIsraelSouth Korea
In The Last Decade
Laura E. Benjamin
70 papers receiving 10.6k citations
Hit Papers
Peers
Comparison fields: 5 of 140
- Cancer Research 2.8k
- Immunology and Allergy 693
- Molecular Biology 6.9k
- Oncology 2.6k
- Cell Biology 1.1k
Countries citing papers authored by Laura E. Benjamin
This map shows the geographic impact of Laura E. Benjamin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura E. Benjamin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura E. Benjamin more than expected).
Fields of papers citing papers by Laura E. Benjamin
This network shows the impact of papers produced by Laura E. Benjamin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura E. Benjamin. The network helps show where Laura E. Benjamin may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Laura E. Benjamin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 1 | |
| 2 | 2022 | 36 | |
| 3 | 2019 | 16 | |
| 4 | 2014 | 40 | |
| 5 | 2012 | 40 | |
| 6 | 2012 | 1 | |
| 7 | 2012 | 6 | |
| 8 | 2010 | 149 | |
| 9 | 2010 | 293 | |
| 10 | 2009 | 37 | |
| 11 | 2008 | 87 | |
| 12 | Pathological angiogenesis is induced by sustained Akt signaling and inhibited by rapamycin. | 2006 | 6 |
| 13 | 2006 | 356 | |
| 14 | 2005 | 130 | |
| 15 | 2004 | 37 | |
| 16 | 2002 | 436 | |
| 17 | 2002 | 8 | |
| 18 | 2001 | 55 | |
| 19 | 2000 | 32 | |
| 20 | 1994 | 37 |
About Laura E. Benjamin
Laura E. Benjamin is a scholar working on Cancer Research, Molecular Biology and Immunology and Allergy, having authored 70 papers that have together received 10.8k indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (34 papers), Cancer, Hypoxia, and Metabolism (16 papers), PI3K/AKT/mTOR signaling in cancer (9 papers), Lymphatic System and Diseases (6 papers), Hippo pathway signaling and YAP/TAZ (5 papers), Vascular Tumors and Angiosarcomas (4 papers), Sarcoma Diagnosis and Treatment (4 papers) and Cell Adhesion Molecules Research (4 papers). The work is most often cited by research in Cancer Research (2.8k citations), Immunology and Allergy (693 citations) and Molecular Biology (6.9k citations). Laura E. Benjamin has collaborated with scholars based in United States, Israel and South Korea. Frequent co-authors include Gabriele Bergers, Eli Keshet, Itzhak Hemo, Ahuva Itin, Dov Pode, Dragan Golijanin, Janice A. Nagy, Harold F. Dvorak, Ann M. Dvořàk and Huiyan Zeng. Their work appears in journals such as Cancer Research, Proceedings of the National Academy of Sciences, American Journal Of Pathology, Circulation and Cancer Biology & Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.